Notice: This company has been marked as potentially delisted and may not be actively trading. Societal CDMO (SCTL) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period CoreRx, Societal CDMO, and Bend Bioscience Unite Under the Bend Bioscience Brand to Provide World Class CDMO offeringSeptember 4, 2024 | tmcnet.comSocietal CDMO, Inc. (NASDAQ:SCTL) Short Interest Down 99.1% in MarchSocietal CDMO, Inc. (NASDAQ:SCTL - Get Free Report) was the recipient of a large drop in short interest during the month of March. As of March 31st, there was short interest totalling 2,400 shares, a drop of 99.1% from the March 15th total of 271,500 shares. Based on an average daily volume of 7,100 shares, the days-to-cover ratio is presently 0.3 days.April 10, 2024 | marketbeat.comCoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.April 8, 2024 | globenewswire.comCoreRx, Inc. Completes Acquisition of Societal CDMO, Inc.April 8, 2024 | businesswire.comTrading was temporarily halted for "SCTL" at 07:04 PM with a stated reason of "News pending."April 8, 2024 | marketbeat.comSocietal CDMO, Inc. (NASDAQ:SCTL) Short Interest Up 82.8% in MarchSocietal CDMO, Inc. (NASDAQ:SCTL - Get Free Report) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 271,500 shares, a growth of 82.8% from the February 29th total of 148,500 shares. Based on an average daily volume of 922,800 shares, the short-interest ratio is currently 0.3 days. Approximately 0.3% of the company's stock are short sold.March 28, 2024 | marketbeat.comSCTL Stock Earnings: Societal CDMO Beats Revenue for Q4 2023March 25, 2024 | investorplace.comSocietal CDMO (NASDAQ:SCTL) Releases Earnings ResultsSocietal CDMO (NASDAQ:SCTL - Get Free Report) issued its earnings results on Friday. The company reported ($0.01) earnings per share (EPS) for the quarter. Societal CDMO had a negative return on equity of 25.04% and a negative net margin of 23.75%.March 23, 2024 | marketbeat.comSocietal CDMO, Inc. (NASDAQ:SCTL) Short Interest Down 20.1% in FebruarySocietal CDMO, Inc. (NASDAQ:SCTL - Get Free Report) was the recipient of a significant drop in short interest during the month of February. As of February 29th, there was short interest totalling 148,500 shares, a drop of 20.1% from the February 14th total of 185,800 shares. Approximately 0.2% of the company's stock are sold short. Based on an average daily volume of 753,800 shares, the short-interest ratio is currently 0.2 days.March 14, 2024 | marketbeat.comSOCIETAL CDMO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Societal CDMO, Inc. - SCTLMarch 13, 2024 | businesswire.comOwning 36% shares,institutional owners seem interested in Societal CDMO, Inc. (NASDAQ:SCTL),March 12, 2024 | finance.yahoo.comSOCIETAL CDMO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Societal CDMO, Inc. - SCTLMarch 1, 2024 | businesswire.comSocietal CDMO, Inc.: Societal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.February 29, 2024 | finanznachrichten.deWhy Is Biotech/Pharma Contract Service Provider Societal CDMO Stock Trading Higher On Thursday?February 29, 2024 | msn.comRoyal Bank of Canada Reaffirms Sector Perform Rating for Societal CDMO (NASDAQ:SCTL)Royal Bank of Canada reiterated a "sector perform" rating and set a $1.10 target price (down previously from $1.25) on shares of Societal CDMO in a research report on Thursday.February 29, 2024 | marketbeat.comWhy Is Societal CDMO (SCTL) Stock Up 133% Today?February 29, 2024 | investorplace.comSocietal CDMO stock soars 133% on takeover dealFebruary 28, 2024 | msn.comSCTL Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Societal CDMO, Inc. Is Fair to ShareholdersFebruary 28, 2024 | businesswire.comSocietal CDMO Enters Into Definitive Agreement to be Acquired by CoreRx, Inc.February 28, 2024 | globenewswire.comTrading was temporarily halted for "SCTL" at 04:02 PM with a stated reason of "News pending."February 28, 2024 | marketbeat.comSocietal CDMO Reaches US$52m Market Cap Benefiting Insider Stock BuyingFebruary 10, 2024 | finance.yahoo.comSocietal CDMO Stock (NASDAQ:SCTL) Dividends: History, Yield and DatesFebruary 6, 2024 | benzinga.comSocietal CDMO and Benuvia Sign Co-Marketing Agreement Designed to Promote Complementary CDMO and API Manufacturing Services to Drug DevelopersFebruary 1, 2024 | finance.yahoo.comSocietal CDMO, Inc.'s (NASDAQ:SCTL) Intrinsic Value Is Potentially 98% Above Its Share PriceDecember 31, 2023 | finance.yahoo.comSocietal CDMO Inc SCTLDecember 9, 2023 | morningstar.comSocietal CDMO, Inc. (NASDAQ:SCTL) Q3 2023 Earnings Call TranscriptNovember 10, 2023 | finance.yahoo.comSocietal CDMO, Inc.: Societal CDMO Reports Third Quarter 2023 Financial ResultsNovember 9, 2023 | finanznachrichten.deRecap: Societal CDMO Q3 EarningsNovember 8, 2023 | benzinga.comSocietal CDMO Reports Third Quarter 2023 Financial ResultsNovember 8, 2023 | finance.yahoo.comSocietal CDMO Inc (SCTL) Reports Q3 2023 Financial Results Amidst Strategic ReorganizationNovember 8, 2023 | finance.yahoo.comEarnings Preview: Societal CDMONovember 7, 2023 | benzinga.comSocietal CDMO to Report Financial Results for Third Quarter 2023 on November 8, 2023November 1, 2023 | finance.yahoo.comSocietal CDMO to Participate in RBC Capital Markets Virtual CDMO ConferenceSeptember 25, 2023 | finance.yahoo.comSocietal CDMO, Inc.: Societal CDMO Announces Corporate RestructuringSeptember 22, 2023 | finanznachrichten.deSocietal CDMO Announces Corporate RestructuringSeptember 20, 2023 | finance.yahoo.comSocietal CDMO Inc.September 11, 2023 | barrons.comSocietal CDMO Secures Project Expansion Agreements With Several Existing CustomersSeptember 7, 2023 | finance.yahoo.comPresident of Societal CDMO J. Enloe Buys 36% More SharesAugust 31, 2023 | finance.yahoo.comPositive Signs As Multiple Insiders Buy Societal CDMO StockAugust 31, 2023 | finance.yahoo.comSocietal CDMO Announces Closing of $8.3 Million Public Offering of Common StockAugust 29, 2023 | finance.yahoo.comSocietal CDMO Shares Slide Premarket After Offer Pricing >SCTLAugust 24, 2023 | marketwatch.comSocietal CDMO Announces Pricing of $8.3 Million Public Offering of Common StockAugust 24, 2023 | finance.yahoo.comUnmasking the Value Trap: An In-Depth Analysis of Societal CDMO Inc (SCTL)August 24, 2023 | finance.yahoo.comUnraveling the Challenges Ahead for Societal CDMO IncAugust 24, 2023 | finance.yahoo.comSocietal CDMO, Inc.: Societal CDMO Announces Appointment of Matt Arens to Board of DirectorsAugust 24, 2023 | finanznachrichten.deSocietal CDMO Announces Appointment of Matt Arens to Board of DirectorsAugust 23, 2023 | finance.yahoo.comSocietal CDMO Announces Proposed Public Offering of Common StockAugust 23, 2023 | finance.yahoo.com$21.8M Revenue For NASDAQ-Listed Psychedelics Ancillary Company Societal CDMO's Q2 2023August 16, 2023 | benzinga.comSCTL: Winning Business Despite Difficult Environment; Expanding Core Capabilities to Increase Service OfferingsAugust 16, 2023 | finance.yahoo.comQ2 2023 Societal CDMO Inc Earnings CallAugust 15, 2023 | finance.yahoo.com Get Societal CDMO News Delivered to You Automatically Sign up to receive the latest news and ratings for SCTL and its competitors with MarketBeat's FREE daily newsletter. Email Address SCTL Media Mentions By Week SCTL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SCTL News Sentiment▼0.000.44▲Average Medical News Sentiment SCTL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SCTL Articles This Week▼00▲SCTL Articles Average Week Get Societal CDMO News Delivered to You Automatically Sign up to receive the latest news and ratings for SCTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Keros Therapeutics News Today Savara News Today GH Research News Today Sage Therapeutics News Today Mereo BioPharma Group News Today SIGA Technologies News Today Phathom Pharmaceuticals News Today PureTech Health News Today Arcturus Therapeutics News Today KalVista Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SCTL) was last updated on 2/5/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNew crypto boom will be greatest in historyUrgent Notice from Ian King, the Crypto Expert Who Made 18,325% in a Year: “Donald Trump’s second term is t...Banyan Hill Publishing | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Societal CDMO, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Societal CDMO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
